EH
TAK icon

Equitable Holdings’s Takeda Pharmaceutical TAK Stock Holding History

Equitable Holdings’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,613
Closed -$181K – 1889
2026
Q1 		$181K Buy
11,613
+773
+7% +$13.6K ﹤0.01% 1610
2025
Q4 		$169K Sell
10,840
-8,643
-44% -$124K ﹤0.01% 1507
2025
Q3 		$285K Buy
+19,483
New +$289K ﹤0.01% 1287

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Equitable Holdings's TAK Position: Q2 2026 in Review

Equitable Holdings sold out of Takeda Pharmaceutical (TAK) in Q2 2026, closing a stake of 11,613 shares — an estimated $181K sold.

Equitable Holdings first reported a position in TAK in Q3 2025 and held it in 3 quarters. The position peaked at $285K in Q3 2025. 378 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Equitable Holdings reported no remaining Takeda Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Equitable Holdings sold 11,613 Takeda Pharmaceutical shares in Q2 2026, an estimated $181K.
  • Equitable Holdings first reported a position in Takeda Pharmaceutical in Q3 2025 and held it in 3 quarters.
  • Equitable Holdings's Takeda Pharmaceutical position peaked at $285K in Q3 2025.
  • 378 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Equitable Holdings's 13F filing for Q2 2026, filed 17 Aug 2026.